Abstract
Thirty-eight pretreated patients with Hodgkin's disease (HD) and malignant non-Hodgkin's lymphoma were given combination chemotherapy with VM-26, Adriamycin, bleomycin, and prednisone. Four of 15 evaluable patients with HD achieved a partial remission (PR), with a median duration of 8 months. Of 12 patients with diffuse poorly differentiated lymphocytic lymphoma, one achieved a complete remission (30+ months) and five achieved a PR (median, 6 months). One of three patients with histiocytic lymphoma had a PR of 1.5 months. There was one drug-related death. Five patients developed life-threatening hematologic toxicity. Two HD responders died of acute nonlymphocytic leukemia.
| Original language | English |
|---|---|
| Pages (from-to) | 335-337 |
| Number of pages | 3 |
| Journal | Cancer Treatment Reports |
| Volume | 64 |
| Issue number | 2-3 |
| Publication status | Published - 1980 |
Fingerprint
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Combination chemotherapy with VM-26, adriamycin, bleomycin, and prednisone as a secondary treatment of malignant lymphoma. / Goldhirsch, A.; Pirovino, M.; Sonntag, R. W.; Tschopp, L.; Ryssel, H. J.; Brunner, K. W.
In: Cancer Treatment Reports, Vol. 64, No. 2-3, 1980, p. 335-337.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Combination chemotherapy with VM-26, adriamycin, bleomycin, and prednisone as a secondary treatment of malignant lymphoma
AU - Goldhirsch, A.
AU - Pirovino, M.
AU - Sonntag, R. W.
AU - Tschopp, L.
AU - Ryssel, H. J.
AU - Brunner, K. W.
PY - 1980
Y1 - 1980
N2 - Thirty-eight pretreated patients with Hodgkin's disease (HD) and malignant non-Hodgkin's lymphoma were given combination chemotherapy with VM-26, Adriamycin, bleomycin, and prednisone. Four of 15 evaluable patients with HD achieved a partial remission (PR), with a median duration of 8 months. Of 12 patients with diffuse poorly differentiated lymphocytic lymphoma, one achieved a complete remission (30+ months) and five achieved a PR (median, 6 months). One of three patients with histiocytic lymphoma had a PR of 1.5 months. There was one drug-related death. Five patients developed life-threatening hematologic toxicity. Two HD responders died of acute nonlymphocytic leukemia.
AB - Thirty-eight pretreated patients with Hodgkin's disease (HD) and malignant non-Hodgkin's lymphoma were given combination chemotherapy with VM-26, Adriamycin, bleomycin, and prednisone. Four of 15 evaluable patients with HD achieved a partial remission (PR), with a median duration of 8 months. Of 12 patients with diffuse poorly differentiated lymphocytic lymphoma, one achieved a complete remission (30+ months) and five achieved a PR (median, 6 months). One of three patients with histiocytic lymphoma had a PR of 1.5 months. There was one drug-related death. Five patients developed life-threatening hematologic toxicity. Two HD responders died of acute nonlymphocytic leukemia.
UR - http://www.scopus.com/inward/record.url?scp=0018851047&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018851047&partnerID=8YFLogxK
M3 - Article
C2 - 6157468
AN - SCOPUS:0018851047
VL - 64
SP - 335
EP - 337
JO - Cancer Treatment Reports
JF - Cancer Treatment Reports
SN - 0361-5960
IS - 2-3
ER -